20.01.2011
- French drugmaker Sanofi-Aventis is likely to extend its $18.5 billion tender offer for Genzyme one last time as it seeks to buy the U.S. maker of drugs for rare diseases, sources...
12.01.2011
- Genzyme, the subject of an $18.5 billion hostile takeover bid from Sanofi-Aventis SA, posted preliminary Q4 earnings that fell short of Wall Street forecasts and cut its earnings...
11.01.2011
- Genzyme acknowledged on Monday that it was discussing a takeover deal with French drugmaker Sanofi-Aventis, but hopes for a quick agreement cooled as both sides noted differences...
10.01.2011
- French drugmaker Sanofi-Aventis and Genzyme Corp are discussing options for significantly raising Sanofi's bid for the the U.S. biotech company to about $80 per share, the Wall...
07.01.2011
- Could it be time to talk in the long-running saga of Sanofi-Aventis $18.5 billion bid for Genzyme Corp? There is certainly the opportunity. The two chief executives at the center...
21.12.2010
- Genzyme argued that its experimental multiple sclerosis treatment will garner far higher sales than Sanofi-Aventis is projecting, as it aims to wrest a significantly higher bid...
06.12.2010
- Genzyme shareholder and board member Ralph Whitworth said the "ingredients are there" for a deal with Sanofi-Aventis , but the French drugmaker's $69-a-share offer is "not even a...
